Fig. 1. Schematic of the experimental design.
(A) Schematic design of the TDP study of metastatic (SW620) and nonmetastatic (SW480) CRC cells using CZE-ESI-MS/MS and LC-CZE-ESI-MS/MS for proteoform ID and LFQ. (B) Four CZE-MS/MS–based strategies in this work with the amounts of protein starting materials.